Johns Hopkins Psychedelic Research Center

Please watch and share our PSA on psychedelic risks and adverse events. It is important to have an evidence-based perspective on the risk/benefit profile of psychedelics: youtube.com/watch?v=xUS2I8…

Working on getting a bibliography of sorts for psychedelic ethics/philosophy papers together - sharing in case it comes in useful for anyone else! Ongoing project & please feel free to let me know if I've missed something 🌿 katcheung.com/psychedelic-et…

We are seeking veterans who have experience with psilocybin and MDMA to fill out a brief 5-10 minute survey about their experiences. Click the link below to contribute to our research 👇

🚨 Call for Abstracts! We're reviving the Lost Foundations of Psychedelic Science! This special issue of Psychedelic Medicine will explore forgotten studies, untranslated breakthroughs, and under-explored leads from the first era of psychedelic research. Read the open call here:…

Associate Director, Dr. Albert Garcia-Romeu shared his insights on psychedelic therapies for psychiatric disorders. He explains the science, shifting public perception, and potential for future FDA approval for these therapies.

Easily one of the best conferences I have attended so far! @GordonConf Shout out to the leadership of @kwanalexc @VVyazovskiy @MelissaHerman4 @ViditaVaidya This experience had so many highlights (but apparently, I can only post 4 pictures in one post). #GRCPsychedelics

CPCR faculty David Yaden (@existwell) presented and participated in a panel on The Evolving Theory for Explaining Psychedelic Drug Action with Mark Geyer, Harriet de Wit, Franz Vollenweider, Bryan Roth, and Scott Thompson at #GRCPsychedelics

Amazing pre-clinical poster session at #GRCPsychedelics. Play the "Where's Waldo" of @JHPsychedelics postdocs and faculty. 5 is the number to beat.

Curious about psychedelic therapy? Join CPCR Associate Director, Dr. Albert Garcia-Romeu for the American Psychological Associations @APA Psychedelics: From Research to Clinical Practice training on Sept 13. Open to clinicians, researchers, and anyone eager to understand this…

‼️NEW STUDY FOR HEALTHY VOLUNTEERS‼️ Join our study at Johns Hopkins exploring how psilocybin—a naturally occurring compound in mushrooms—affects brain activity and function. Our study uses safe, noninvasive methods like EEG, fMRI, transcranial magnetic stimulation (TMS), and…

Interested in becoming a psychedelic therapist? We’re seeking a full-time therapist to join our team and support innovative clinical trials exploring the therapeutic potential of psychedelics. Learn more and apply here: jobs.jhu.edu/job/Balitmore-…

Last week, CPCR researchers Drs. Fred Barrett, Brandon Weiss, David Yaden, and Sandeep Nayak met with the PATH Caucus (led by @RepLouCorrea and @RepJackBergman) on Capitol Hill. In a vibrant meeting of oral presentations and Q&A, Drs. Barrett and Weiss shared their scientific…

We are learning so much from our clinical trial (PI @sdpnayak) examining Psilocybin Therapy for PTSD. Here are a few of the areas we're learning about: -How do SSRIs affect the intensity of experience? -What role can trauma-focused psychotherapy play following psilocybin?

That’s a wrap on Psychedelic Science 2025! We had a fantastic time presenting our research and connecting with both new and familiar faces in the field. Grateful for the conversations, collaborations, and inspiration. Excited for what’s ahead! @PsychedelicSci @MAPS @BWe1ss…